These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8068944)

  • 1. The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: evidence for an indirect mechanism.
    Cashman JD; Eaves AC; Eaves CJ
    Blood; 1994 Sep; 84(5):1534-42. PubMed ID: 8068944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCP-1, not MIP-1alpha, is the endogenous chemokine that cooperates with TGF-beta to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures.
    Cashman JD; Eaves CJ; Sarris AH; Eaves AC
    Blood; 1998 Oct; 92(7):2338-44. PubMed ID: 9746772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells.
    Eaves CJ; Cashman JD; Wolpe SD; Eaves AC
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):12015-9. PubMed ID: 8265663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-beta on normal and leukemic human hematopoietic progenitor cells.
    Cashman JD; Eaves AC; Eaves CJ
    Leukemia; 1992 Sep; 6(9):886-92. PubMed ID: 1518302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the inhibitory effect of AcSDKP, TNF-alpha, TGF-beta, and MIP-1 alpha on marrow-purified CD34+ progenitors.
    Bonnet D; Lemoine FM; Najman A; Guigon M
    Exp Hematol; 1995 Jun; 23(6):551-6. PubMed ID: 7539383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biology of normal and neoplastic stem cells in CML.
    Eaves C; Udomsakdi C; Cashman J; Barnett M; Eaves A
    Leuk Lymphoma; 1993; 11 Suppl 1():245-53. PubMed ID: 8251904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.
    Holyoake TL; Freshney MG; Sproul AM; Richmond LJ; Alcorn MJ; Steward WP; Fitzsimons E; Dunlop DJ; Franklin IM; Pragnell IB
    Stem Cells; 1993 Oct; 11 Suppl 3():122-8. PubMed ID: 8298472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
    Jackson JD; Yan Y; Ewel C; Talmadge JE
    Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of acetyl-Ser-Asp-Lys-Pro (AcSDKP) on human hematopoietic progenitor cells in short-term and long-term bone marrow cultures.
    Jackson JD; Ozerol E; Yan Y; Ewel C; Talmadge JE
    J Hematother Stem Cell Res; 2000 Aug; 9(4):489-96. PubMed ID: 10982247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible inhibitory effects and absence of toxicity of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in human long-term bone marrow culture.
    Bonnet D; Lemoine FM; Khoury E; Pradelles P; Najman A; Guigon M
    Exp Hematol; 1992 Nov; 20(10):1165-9. PubMed ID: 1385195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
    Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
    Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tetrapeptide AcSDKP, an inhibitor of the cell-cycle status for normal human hematopoietic progenitors, has no effect on leukemic cells.
    Bonnet D; Césaire R; Lemoine F; Aoudjhane M; Najman A; Guigon M
    Exp Hematol; 1992 Feb; 20(2):251-5. PubMed ID: 1544396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progenitor cells in the blood and marrow of patients with chronic phase chronic myeloid leukaemia respond differently to macrophage inflammatory protein-1 alpha.
    Nirsimloo N; Gordon MY
    Leuk Res; 1995 May; 19(5):319-23. PubMed ID: 7769832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells.
    Otsuka T; Eaves CJ; Humphries RK; Hogge DE; Eaves AC
    Leukemia; 1991 Oct; 5(10):861-8. PubMed ID: 1961020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice.
    Cashman J; Clark-Lewis I; Eaves A; Eaves C
    Blood; 2002 Feb; 99(3):792-9. PubMed ID: 11806978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
    Karlic H; Louda N; Pfeilstöcker M; Keil F; Lohninger A; Pittermann E; Paukovits J
    Stem Cells; 2001; 19(4):321-8. PubMed ID: 11463952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hematopoiesis in long-term marrow cultures established on adherent layers from AcSDKP-treated dogs.
    Hong DS; Graham T; Ewel C; Storb R; Deeg HJ
    Exp Hematol; 1995 Jul; 23(7):639-44. PubMed ID: 7601256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage inflammatory protein-1 alpha receptors are present on cells enriched for CD34 expression from patients with chronic myeloid leukemia.
    Chasty RC; Lucas GS; Owen-Lynch PJ; Pierce A; Whetton AD
    Blood; 1995 Dec; 86(11):4270-7. PubMed ID: 7492787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
    Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.
    Carlo-Stella C; Dotti G; Mangoni L; Regazzi E; Garau D; Bonati A; Almici C; Sammarelli G; Savoldo B; Rizzo MT; Rizzoli V
    Blood; 1996 Oct; 88(8):3091-100. PubMed ID: 8874208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.